Morphologically, the centroblastic variant comprised a large proportion in both CD5+ and CD5- DLBCL (21 of 24, 87.5% vs. 21 of 23, 91.3%, P > 0.999). The gene discussed is CD5; the disease is diffuse large B-cell lymphoma.